On the public citation graph

Current Strategies to Enhance Delivery of Drugs across the Blood–Brain Barrier

https://doi.org/10.3390/pharmaceutics14050987

0 signed · 385 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

1 of the 189 references listed on this page is in the Retraction Watch database as retracted (export 2026-10-21): 10.1007/s11356-021-17830-7 (notice 2026-06-27).

Dataset join, best-effort; this page does not check the publisher record. Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0); dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/1097-0134(20010501)43:2<89::aid-prot1021>3.0.co;2-hopenalex-snapshot

Residue frequencies and pairing preferences at protein-protein interfaces

inferredcites →https://doi.org/10.1002/1873-3468.13966openalex-snapshot

Structures of ABC transporters: handle with care

inferredcites →https://doi.org/10.1002/adtp.201900073openalex-snapshot

Delivery of Nanoparticles and Macromolecules across the Blood–Brain Barrier

inferredcites →https://doi.org/10.1002/advs.201902583openalex-snapshot

Transcranial Pulse Stimulation with Ultrasound in Alzheimer's Disease—A New Navigated Focal Brain Therapy

inferredcites →https://doi.org/10.1002/ana.10506openalex-snapshot

Cerebral neurogenesis is induced by intranasal administration of growth factors

inferredcites →https://doi.org/10.1002/ijc.29417openalex-snapshot

Extracellular vesicles as carriers of microRNA, proteins and lipids in tumor microenvironment

inferredcites →https://doi.org/10.1002/jcp.27669openalex-snapshot

Interaction between mesenchymal stromal cell‐derived extracellular vesicles and immune cells by distinct protein content

inferredcites →https://doi.org/10.1007/8904_2018_110openalex-snapshot

Evaluation of Disease Lesions in the Developing Canine MPS IIIA Brain

inferredcites →https://doi.org/10.1007/978-3-662-58614-3openalex-snapshot

JIMD Reports, Volume 43

inferredcites →https://doi.org/10.1007/bf03206641openalex-snapshot

Development of neuropeptide drugs that cross the blood-brain barrier

inferredcites →https://doi.org/10.1007/s00210-021-02096-0openalex-snapshot

Pharmacokinetic and pharmacodynamic evaluation of nasal liposome and nanoparticle based rivastigmine formulations in acute and chronic models of Alzheimer’s disease

inferredcites →https://doi.org/10.1007/s00401-011-0847-6openalex-snapshot

Brain microvascular pericytes in health and disease

inferredcites →https://doi.org/10.1007/s00424-020-02441-xopenalex-snapshot

Glucose transporters in brain in health and disease

inferredcites →https://doi.org/10.1007/s11030-016-9715-6openalex-snapshot

The role of multidrug resistance protein (MRP-1) as an active efflux transporter on blood–brain barrier (BBB) permeability

inferredcites →https://doi.org/10.1007/s11095-009-9964-5openalex-snapshot

Uptake of ANG1005, A Novel Paclitaxel Derivative, Through the Blood-Brain Barrier into Brain and Experimental Brain Metastases of Breast Cancer

inferredcites →https://doi.org/10.1007/s11095-013-1156-7openalex-snapshot

Nanotechnology-Based Drug Delivery Systems for Targeting, Imaging and Diagnosis of Neurodegenerative Diseases

inferredcites →https://doi.org/10.1007/s11356-021-17830-7openalex-snapshot

RETRACTED ARTICLE: Potential innovation against Alzheimer’s disorder: a tricomponent combination of natural antioxidants (vitamin E, quercetin, and basil oil) and the development of its intranasal delivery

inferredcites →https://doi.org/10.1007/s13318-017-0411-4openalex-snapshot

Therapeutic Potential and Utility of Elacridar with Respect to P-glycoprotein Inhibition: An Insight from the Published In Vitro, Preclinical and Clinical Studies

inferredcites →https://doi.org/10.1007/s40263-016-0405-9openalex-snapshot

Crossing the Blood–Brain Barrier: Recent Advances in Drug Delivery to the Brain

inferredcites →https://doi.org/10.1016/0169-409x(95)00003-popenalex-snapshot

Transport of small molecules through the blood-brain barrier: biology and methodology

inferredcites →https://doi.org/10.1016/bs.irn.2020.03.001openalex-snapshot

Pathophysiology of blood-brain barrier in brain tumor. Novel therapeutic advances using nanomedicine

inferredcites →https://doi.org/10.1016/j.actbio.2016.10.009openalex-snapshot

Development of a novel imaging agent using peptide-coated gold nanoparticles toward brain glioma stem cell marker CD133

inferredcites →https://doi.org/10.1016/j.bbadis.2019.01.004openalex-snapshot

Adenosine receptors as a new target for resveratrol-mediated glioprotection

inferredcites →https://doi.org/10.1016/j.bbagen.2016.12.020openalex-snapshot

Iron oxide nanoparticle surface decorated with cRGD peptides for magnetic resonance imaging of brain tumors

inferredcites →https://doi.org/10.1016/j.beem.2014.12.001openalex-snapshot

Neuronopathic lysosomal storage disorders: Approaches to treat the central nervous system

inferredcites →https://doi.org/10.1016/j.bioelechem.2014.06.001openalex-snapshot

Dynamic effects of point source electroporation on the rat brain tissue

inferredcites →https://doi.org/10.1016/j.chemosphere.2021.129579openalex-snapshot

High concentration of blood cobalt is associated with the impairment of blood-brain barrier permeability

inferredcites →https://doi.org/10.1016/j.colsurfb.2017.10.062openalex-snapshot

Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation

inferredcites →https://doi.org/10.1016/j.cub.2018.01.059openalex-snapshot

Exosomes and Ectosomes in Intercellular Communication

inferredcites →https://doi.org/10.1016/j.ddtec.2016.07.007openalex-snapshot

Ultrasound-mediated drug delivery to the brain: principles, progress and prospects

inferredcites →https://doi.org/10.1016/j.drudis.2021.04.008openalex-snapshot

Recent advances in nano delivery systems for blood-brain barrier (BBB) penetration and targeting of brain tumors

inferredcites →https://doi.org/10.1016/j.drup.2015.02.002openalex-snapshot

Overcoming the blood–brain tumor barrier for effective glioblastoma treatment

inferredcites →https://doi.org/10.1016/j.expneurol.2015.11.013openalex-snapshot

Low-dose, continual enzyme delivery ameliorates some aspects of established brain disease in a mouse model of a childhood-onset neurodegenerative disorder

inferredcites →https://doi.org/10.1016/j.ijpharm.2021.120351openalex-snapshot

Evolving new-age strategies to transport therapeutics across the blood-brain-barrier

inferredcites →https://doi.org/10.1016/j.intimp.2018.12.001openalex-snapshot

Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia

inferredcites →https://doi.org/10.1016/j.jacbts.2019.10.008openalex-snapshot

Limitations of Animal Studies for Predicting Toxicity in Clinical Trials

inferredcites →https://doi.org/10.1016/j.jconrel.2009.01.010openalex-snapshot

Preparation and in vivo imaging of PEG-poly(L-lysine)-based polymeric micelle MRI contrast agents

inferredcites →https://doi.org/10.1016/j.jconrel.2016.01.009openalex-snapshot

PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time

inferredcites →https://doi.org/10.1016/j.jconrel.2016.10.011openalex-snapshot

Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption

inferredcites →https://doi.org/10.1016/j.jconrel.2017.03.020openalex-snapshot

A polymeric micelle magnetic resonance imaging (MRI) contrast agent reveals blood–brain barrier (BBB) permeability for macromolecules in cerebral ischemia-reperfusion injury

inferredcites →https://doi.org/10.1016/j.jconrel.2018.03.006openalex-snapshot

Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma

inferredcites →https://doi.org/10.1016/j.jconrel.2019.06.033openalex-snapshot

Dual functionalized liposomes for efficient co-delivery of anti-cancer chemotherapeutics for the treatment of glioblastoma

inferredcites →https://doi.org/10.1016/j.jconrel.2019.07.023openalex-snapshot

Safety and efficacy of focused ultrasound induced blood-brain barrier opening, an integrative review of animal and human studies

inferredcites →https://doi.org/10.1016/j.jconrel.2020.07.042openalex-snapshot

Surface functionalization of exosomes for target-specific delivery and in vivo imaging & tracking: Strategies and significance

inferredcites →https://doi.org/10.1016/j.jneuroim.2004.02.011openalex-snapshot

Intranasal administration of interferon beta bypasses the blood–brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis

inferredcites →https://doi.org/10.1016/j.jstrokecerebrovasdis.2004.01.005openalex-snapshot

The window of opportunity for treatment of focal cerebral ischemic damage with noninvasive intranasal insulin-like growth factor-I in rats

inferredcites →https://doi.org/10.1016/j.lfs.2021.119142openalex-snapshot

Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection

inferredcites →https://doi.org/10.1016/j.mcn.2016.10.007openalex-snapshot

Systemic application of AAV vectors targeting GFAP-expressing astrocytes in Z -Q175-KI Huntington's disease mice

inferredcites →https://doi.org/10.1016/j.mri.2016.11.023openalex-snapshot

Pharmacokinetic analysis and drug delivery efficiency of the focused ultrasound-induced blood-brain barrier opening in non-human primates

inferredcites →https://doi.org/10.1016/j.nano.2018.01.004openalex-snapshot

The enhancement of siPLK1 penetration across BBB and its anti glioblastoma activity in vivo by magnet and transferrin co-modified nanoparticle

inferredcites →https://doi.org/10.1016/j.nbd.2003.12.016openalex-snapshot

The blood–brain barrier: an overview

inferredcites →https://doi.org/10.1016/j.neuint.2018.03.002openalex-snapshot

X-ray irradiation induces disruption of the blood–brain barrier with localized changes in claudin-5 and activation of microglia in the mouse brain

inferredcites →https://doi.org/10.1016/j.neuron.2008.01.003openalex-snapshot

The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders

inferredcites →https://doi.org/10.1016/j.neuropharm.2016.08.025openalex-snapshot

Targeting blood-brain-barrier transcytosis – perspectives for drug delivery

inferredcites →https://doi.org/10.1016/j.neuroscience.2004.05.029openalex-snapshot

Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration

inferredcites →https://doi.org/10.1016/j.pharmthera.2014.05.009openalex-snapshot

Intrathecal delivery of protein therapeutics to the brain: A critical reassessment

inferredcites →https://doi.org/10.1016/j.tem.2004.07.002openalex-snapshot

Chemotherapy targeted to cancers through tumoral hormone receptors

inferredcites →https://doi.org/10.1016/j.ultrasmedbio.2007.12.015openalex-snapshot

Effect of Focused Ultrasound Applied With an Ultrasound Contrast Agent on the Tight Junctional Integrity of the Brain Microvascular Endothelium

inferredcites →https://doi.org/10.1016/j.ultrasmedbio.2012.03.013openalex-snapshot

Detection of Intracerebral Hemorrhage and Transient Blood-Supply Shortage in Focused-Ultrasound-Induced Blood–Brain Barrier Disruption by Ultrasound Imaging

inferredcites →https://doi.org/10.1016/j.ymthe.2003.08.021openalex-snapshot

Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain

inferredcites →https://doi.org/10.1016/s0165-6147(96)80010-1openalex-snapshot

Pharmacology of adenosine A2A receptors

inferredcites →https://doi.org/10.1016/s1473-3099(13)70078-1openalex-snapshot

Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries

inferredcites →https://doi.org/10.1016/s1474-4422(07)70326-5openalex-snapshot

Strategies to advance translational research into brain barriers

inferredcites →https://doi.org/10.1021/acs.bioconjchem.6b00389openalex-snapshot

Gd(III)-Gold Nanoconjugates Provide Remarkable Cell Labeling for High Field Magnetic Resonance Imaging

inferredcites →https://doi.org/10.1021/acs.chemrev.5b00046openalex-snapshot

New Developments in Liposomal Drug Delivery

inferredcites →https://doi.org/10.1021/acsami.7b18135openalex-snapshot

Methotrexate-Loaded Extracellular Vesicles Functionalized with Therapeutic and Targeted Peptides for the Treatment of Glioblastoma Multiforme

inferredcites →https://doi.org/10.1021/acschembio.6b00558openalex-snapshot

Antioxidative Theranostic Iron Oxide Nanoparticles toward Brain Tumors Imaging and ROS Production

inferredcites →https://doi.org/10.1021/acschemneuro.0c00242openalex-snapshot

Solid Lipid Nanoparticles Enhanced the Neuroprotective Role of Curcumin against Epilepsy through Activation of Bcl-2 Family and P38 MAPK Pathways

inferredcites →https://doi.org/10.1021/acschemneuro.8b00044openalex-snapshot

Gadolinium-Free Contrast Agents for Magnetic Resonance Imaging of the Central Nervous System

inferredcites →https://doi.org/10.1021/acscombsci.6b00116openalex-snapshot

Rationally Designed Peptides and Peptidomimetics as Inhibitors of Amyloid-β (Aβ) Aggregation: Potential Therapeutics of Alzheimer’s Disease

inferredcites →https://doi.org/10.1021/acsnano.6b07607openalex-snapshot

Re-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics

inferredcites →https://doi.org/10.1021/bc500291ropenalex-snapshot

Surface Functionalization of Exosomes Using Click Chemistry

inferredcites →https://doi.org/10.1021/ja0268635openalex-snapshot

Glycopeptide-Membrane Interactions: Glycosyl Enkephalin Analogues Adopt Turn Conformations by NMR and CD in Amphipathic Media

inferredcites →https://doi.org/10.1038/41771openalex-snapshot

Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor

inferredcites →https://doi.org/10.1038/433561aopenalex-snapshot

Gene therapy put on hold as third child develops cancer

inferredcites →https://doi.org/10.1038/gim.2015.36openalex-snapshot

A phase I/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis II

inferredcites →https://doi.org/10.1038/gt.2009.85openalex-snapshot

Mannitol-facilitated CNS entry of rAAV2 vector significantly delayed the neurological disease progression in MPS IIIB mice

inferredcites →https://doi.org/10.1038/labinvest.3780100openalex-snapshot

Regulation of Aminopeptidase A in Human Brain Tumor Vasculature: Evidence for a Role of Transforming Growth Factor-β

inferredcites →https://doi.org/10.1038/nmeth.1518openalex-snapshot

Efficient CNS gene delivery by intravenous injection

inferredcites →https://doi.org/10.1038/nrd.2015.21openalex-snapshot

From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery

inferredcites →https://doi.org/10.1038/nrn1824openalex-snapshot

Astrocyte–endothelial interactions at the blood–brain barrier

inferredcites →https://doi.org/10.1038/s41565-021-00858-8openalex-snapshot

Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics

inferredcites →https://doi.org/10.1038/s41568-018-0005-8openalex-snapshot

Revisiting the role of ABC transporters in multidrug-resistant cancer

inferredcites →https://doi.org/10.1038/s41573-021-00139-yopenalex-snapshot

Strategies for delivering therapeutics across the blood–brain barrier

inferredcites →https://doi.org/10.1038/s41598-020-75253-9openalex-snapshot

Investigating the optimum size of nanoparticles for their delivery into the brain assisted by focused ultrasound-induced blood–brain barrier opening

inferredcites →https://doi.org/10.1038/srep21933openalex-snapshot

Engineering hybrid exosomes by membrane fusion with liposomes

inferredcites →https://doi.org/10.1038/srep22595openalex-snapshot

An Unexpected Transient Breakdown of the Blood Brain Barrier Triggers Passage of Large Intravenously Administered Nanoparticles

inferredcites →https://doi.org/10.1038/srep25794openalex-snapshot

Transporter protein and drug-conjugated gold nanoparticles capable of bypassing the blood-brain barrier

inferredcites →https://doi.org/10.1038/srep40358openalex-snapshot

Multimodality MRI assessment of grey and white matter injury and blood-brain barrier disruption after intracerebral haemorrhage in mice

inferredcites →https://doi.org/10.1038/srep41316openalex-snapshot

Impairment of blood-brain barrier is an early event in R6/2 mouse model of Huntington Disease

inferredcites →https://doi.org/10.1039/c7ra07603gopenalex-snapshot

A microfluidic model of the blood–brain barrier to study permeabilization by pulsed electric fields

inferredcites →https://doi.org/10.1039/c7tb01599bopenalex-snapshot

Nanoparticles as contrast agents for brain nuclear magnetic resonance imaging in Alzheimer's disease diagnosis

inferredcites →https://doi.org/10.1042/bst20180147openalex-snapshot

Learning the ABCs one at a time: structure and mechanism of ABC transporters

inferredcites →https://doi.org/10.1056/nejm200101183440304openalex-snapshot

Enzyme-Replacement Therapy in Mucopolysaccharidosis I

inferredcites →https://doi.org/10.1073/pnas.0500195102openalex-snapshot

Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice

inferredcites →https://doi.org/10.1073/pnas.1614336114openalex-snapshot

Dual role of ALCAM in neuroinflammation and blood–brain barrier homeostasis

inferredcites →https://doi.org/10.1073/pnas.192442999openalex-snapshot

Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice

inferredcites →https://doi.org/10.1073/pnas.92.21.9829openalex-snapshot

Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption.

inferredcites →https://doi.org/10.1080/08982104.2019.1668010openalex-snapshot

A comprehensive review on recent preparation techniques of liposomes

inferredcites →https://doi.org/10.1080/10717544.2018.1436099openalex-snapshot

Application of an assay Cascade methodology for a deep preclinical characterization of polymeric nanoparticles as a treatment for gliomas

inferredcites →https://doi.org/10.1080/10717544.2019.1571123openalex-snapshot

Transient blood–brain barrier disruption is induced by low pulsed electrical fields in vitro: an analysis of permeability and trans-endothelial electric resistivity

inferredcites →https://doi.org/10.1080/13543776.2020.1720649openalex-snapshot

Solid lipid nanoparticles: a review on recent perspectives and patents

inferredcites →https://doi.org/10.1080/14728222.2017.1310841openalex-snapshot

The therapeutic potential of targeting ABC transporters to combat multi-drug resistance

inferredcites →https://doi.org/10.1080/17425247.2017.1242574openalex-snapshot

Peptides as a therapeutic avenue for nanocarrier-aided targeting of glioma

inferredcites →https://doi.org/10.1084/jem.20190062openalex-snapshot

The blood–brain barrier in health and disease: Important unanswered questions

inferredcites →https://doi.org/10.1088/1741-2560/7/1/016005openalex-snapshot

DBS-relevant electric fields increase hydraulic conductivity ofin vitroendothelial monolayers

inferredcites →https://doi.org/10.1097/wnr.0000000000001426openalex-snapshot

Ginsenoside Rd attenuates blood-brain barrier damage by suppressing proteasome-mediated signaling after transient forebrain ischemia

inferredcites →https://doi.org/10.1111/adb.12683openalex-snapshot

Ethanol consumption following mild traumatic brain injury is related to blood‐brain barrier permeability

inferredcites →https://doi.org/10.1111/bcp.13301openalex-snapshot

Effect of P‐glycoprotein inhibition at the blood–brain barrier on brain distribution of (R)‐[11C]verapamil in elderly vs. young subjects

inferredcites →https://doi.org/10.1111/jcmm.13695openalex-snapshot

Mechanisms of enhanced antiglioma efficacy of polysorbate 80‐modified paclitaxel‐loaded PLGA nanoparticles by focused ultrasound

inferredcites →https://doi.org/10.1124/dmd.120.000099openalex-snapshot

Impact of P-Glycoprotein–Mediated Active Efflux on Drug Distribution into Lumbar Cerebrospinal Fluid in Nonhuman Primates

inferredcites →https://doi.org/10.1124/jpet.103.053306openalex-snapshot

Comparative Profile of Vasodilation by CVT-3146, a Novel A2A Receptor Agonist, and Adenosine in Conscious Dogs

inferredcites →https://doi.org/10.1124/jpet.104.069393openalex-snapshot

Antinociceptive Structure-Activity Studies with Enkephalin-Based Opioid Glycopeptides

inferredcites →https://doi.org/10.1124/mi.3.2.90openalex-snapshot

BLOOD-BRAIN BARRIER DRUG TARGETING: THE FUTURE OF BRAIN DRUG DEVELOPMENT

inferredcites →https://doi.org/10.1124/pr.110.003285openalex-snapshot

International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update

inferredcites →https://doi.org/10.1124/pr.55.3.1openalex-snapshot

Impact of Drug Transporter Studies on Drug Discovery and Development

inferredcites →https://doi.org/10.1146/annurev-biochem-011520-105201openalex-snapshot

Structural and Mechanistic Principles of ABC Transporters

inferredcites →https://doi.org/10.1152/ajplung.2000.279.6.l1218openalex-snapshot

Reversibility of increased microvessel permeability in response to VE-cadherin disassembly

inferredcites →https://doi.org/10.1155/2018/5837276openalex-snapshot

Gold Nanoparticles as X-Ray, CT, and Multimodal Imaging Contrast Agents: Formulation, Targeting, and Methodology

inferredcites →https://doi.org/10.1161/circresaha.116.306534openalex-snapshot

Protein Interactions at Endothelial Junctions and Signaling Mechanisms Regulating Endothelial Permeability

inferredcites →https://doi.org/10.1166/jnn.2003.077openalex-snapshot

Influence of the Surface Properties on Nanoparticle-Mediated Transport of Drugs to the Brain

inferredcites →https://doi.org/10.1177/0271678x20965500openalex-snapshot

Complete inhibition of ABCB1 and ABCG2 at the blood–brain barrier by co-infusion of erlotinib and tariquidar to improve brain delivery of the model ABCB1/ABCG2 substrate [ 11 C]erlotinib

inferredcites →https://doi.org/10.1186/1471-2202-9-s3-s5openalex-snapshot

Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease

inferredcites →https://doi.org/10.1186/1471-2377-9-s1-s3openalex-snapshot

Characteristics of compounds that cross the blood-brain barrier

inferredcites →https://doi.org/10.1186/1479-5876-7-77openalex-snapshot

Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors

inferredcites →https://doi.org/10.1186/s12987-015-0017-7openalex-snapshot

Adenosine receptor signaling: a key to opening the blood–brain door

inferredcites →https://doi.org/10.1186/s12987-020-00209-0openalex-snapshot

Differential expression of receptors mediating receptor-mediated transcytosis (RMT) in brain microvessels, brain parenchyma and peripheral tissues of the mouse and the human

inferredcites →https://doi.org/10.1186/s12987-020-00230-3openalex-snapshot

A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity

inferredcites →https://doi.org/10.1186/s43094-020-00047-9openalex-snapshot

Exploring different approaches to improve the success of drug discovery and development projects: a review

inferredcites →https://doi.org/10.1208/s12248-016-0015-yopenalex-snapshot

Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer

inferredcites →https://doi.org/10.1210/en.2004-0074openalex-snapshot

Evidence Indicating that Renal Tubular Metabolism of Leptin Is Mediated by Megalin But Not by the Leptin Receptors

inferredcites →https://doi.org/10.1212/wnl.0000000000003566openalex-snapshot

DCE-MRI blood–brain barrier assessment in acute ischemic stroke

inferredcites →https://doi.org/10.1227/01.neu.0000489858.08559.c8openalex-snapshot

370 Magnetic Resonance-Guided Focused Ultrasound Delivery of Polymeric Brain-Penetrating Nanoparticle MicroRNA Conjugates in Glioblastoma

inferredcites →https://doi.org/10.1371/journal.pone.0042817openalex-snapshot

MRI Study on Reversible and Irreversible Electroporation Induced Blood Brain Barrier Disruption

inferredcites →https://doi.org/10.1371/journal.pone.0045992openalex-snapshot

Peripheral Nervous System Neuropathology and Progressive Sensory Impairments in a Mouse Model of Mucopolysaccharidosis IIIB

inferredcites →https://doi.org/10.1371/journal.pone.0166061openalex-snapshot

Effects on P-Glycoprotein Expression after Blood-Brain Barrier Disruption Using Focused Ultrasound and Microbubbles

inferredcites →https://doi.org/10.14283/jpad.2014.25openalex-snapshot

BLOOD-BRAIN BARRIER PERMEABILITY IN AGING AND ALZHEIMER’S DISEASE

inferredcites →https://doi.org/10.14670/hh-11-905openalex-snapshot

The role of endothelial lipase in lipid metabolism, inflammation, and cancer.

inferredcites →https://doi.org/10.1515/revneuro-2018-0080openalex-snapshot

Application of quercetin in neurological disorders: from nutrition to nanomedicine

inferredcites →https://doi.org/10.1517/14656566.9.2.301openalex-snapshot

Liposomal cytarabine for leukemic and lymphomatous meningitis: recent developments

inferredcites →https://doi.org/10.1517/17425247.2014.897693openalex-snapshot

Drug delivery across the blood–brain barrier using focused ultrasound

inferredcites →https://doi.org/10.1523/jneurosci.2962-16.2016openalex-snapshot

Glutamate Induces Blood–Brain Barrier Permeability through Activation ofN-Methyl-D-Aspartate Receptors

inferredcites →https://doi.org/10.1586/14737175.8.1.9openalex-snapshot

Galantamine in Alzheimer’s disease

inferredcites →https://doi.org/10.1602/neurorx.2.1.44openalex-snapshot

Development of neuropeptide drugs that cross the blood-brain barrier

inferredcites →https://doi.org/10.20517/2347-8659.2020.58openalex-snapshot

A review on Parkinson’s disease treatment

inferredcites →https://doi.org/10.20517/cdr.2021.35openalex-snapshot

ATP-binding cassette transporters at the zebrafish blood-brain barrier and the potential utility of the zebrafish as an in vivo model

inferredcites →https://doi.org/10.2147/ijn.s117210openalex-snapshot

Getting into the brain: liposome-based strategies for effective drug delivery across the blood–brain barrier

inferredcites →https://doi.org/10.2147/ijn.s149022openalex-snapshot

Theranostic applications of nanoparticles in neurodegenerative disorders

inferredcites →https://doi.org/10.2147/ijn.s218085openalex-snapshot

Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy

inferredcites →https://doi.org/10.2147/ijn.s87148openalex-snapshot

Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease

inferredcites →https://doi.org/10.2174/1381612823666170913164738openalex-snapshot

The Transport Mechanism of Extracellular Vesicles at the Blood-Brain Barrier

inferredcites →https://doi.org/10.2174/1389200221999201210213036openalex-snapshot

Recent Patents, Regulatory Issues, and Toxicity of Nanoparticles in Neuronal Disorders

inferredcites →https://doi.org/10.2174/138920111795542642openalex-snapshot

Intrathecal Enzyme Replacement Therapy for Mucopolysaccharidosis I: Translating Success in Animal Models to Patients

inferredcites →https://doi.org/10.2174/1567201816666190828153017openalex-snapshot

Crossing the Blood-Brain Barrier: A Review on Drug Delivery Strategies for Treatment of the Central Nervous System Diseases

inferredcites →https://doi.org/10.2174/18755453mteyjmzin3openalex-snapshot

Recent Patents, Regulatory Issues, and Toxicity of Nanoparticles in Neuronal Disorders

inferredcites →https://doi.org/10.2217/nnm.16.15openalex-snapshot

Nanoparticles for Brain-Specific Drug and Genetic Material delivery, Imaging and Diagnosis

inferredcites →https://doi.org/10.2310/jim.0b013e318276de79openalex-snapshot

Physiology and Pathophysiology of the Blood-Brain Barrier: P-Glycoprotein and Occludin Trafficking as Therapeutic Targets to Optimize Central Nervous System Drug Delivery

inferredcites →https://doi.org/10.3109/10717549709051878openalex-snapshot

Delivery of 125 I-NGF to the Brain via the Olfactory Route

inferredcites →https://doi.org/10.33263/briac104.792796openalex-snapshot

Dexamethasone ameliorates Alzheimer’s pathological condition via inhibiting Nf-κB and mTOR signaling pathways

inferredcites →https://doi.org/10.33263/briac106.71357151openalex-snapshot

Emerging Promise of Nanoparticle-Based Treatment for Parkinson’s disease

inferredcites →https://doi.org/10.33263/briac113.98719879openalex-snapshot

Molecular Docking Studies of Flavonoids from Andrographis paniculata as Potential Acetylcholinesterase, Butyrylcholinesterase and Monoamine Oxidase Inhibitors Towards the Treatment of Neurodegenerative Diseases

inferredcites →https://doi.org/10.33263/briac115.1297312984openalex-snapshot

Regulatory Gene Network Pathway among Brain Cancer and Associated Disease: a Computational Analysis

inferredcites →https://doi.org/10.33263/briac115.1345313464openalex-snapshot

Analysis of Pathways in Triple-Negative Breast Cancer Cells Treated with the Combination of Electrochemotherapy and Cisplatin

inferredcites →https://doi.org/10.3389/fncel.2018.00459openalex-snapshot

Neuro-Immune Hemostasis: Homeostasis and Diseases in the Central Nervous System

inferredcites →https://doi.org/10.3389/fneur.2018.00328openalex-snapshot

Gold Nanoparticles for Brain Tumor Imaging: A Systematic Review

inferredcites →https://doi.org/10.3389/fnins.2017.00086openalex-snapshot

Increasing of Blood-Brain Tumor Barrier Permeability through Transcellular and Paracellular Pathways by Microbubble-Enhanced Diagnostic Ultrasound in a C6 Glioma Model

inferredcites →https://doi.org/10.3389/fnins.2018.01019openalex-snapshot

Transcytosis to Cross the Blood Brain Barrier, New Advancements and Challenges

inferredcites →https://doi.org/10.3389/fonc.2020.561936openalex-snapshot

Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics

inferredcites →https://doi.org/10.3389/fphar.2012.00074openalex-snapshot

The Role of ATP-Binding Cassette Transporters in Neuro-Inflammation: Relevance for Bioactive Lipids

inferredcites →https://doi.org/10.3390/biom11050633openalex-snapshot

Modulation of Blood–Brain Barrier Permeability by Activating Adenosine A2 Receptors in Oncological Treatment

inferredcites →https://doi.org/10.3390/cells9030785openalex-snapshot

Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases

inferredcites →https://doi.org/10.3390/ijms19123837openalex-snapshot

Targeting Adenosine Receptor Signaling in Cancer Immunotherapy

inferredcites →https://doi.org/10.3390/ijms22073742openalex-snapshot

Disease-Induced Modulation of Drug Transporters at the Blood–Brain Barrier Level

inferredcites →https://doi.org/10.3390/nano8030178openalex-snapshot

Transferrin Functionalized Liposomes Loading Dopamine HCl: Development and Permeability Studies across an In Vitro Model of Human Blood–Brain Barrier

inferredcites →https://doi.org/10.3390/nano9030474openalex-snapshot

Application of Solid Lipid Nanoparticles to Improve the Efficiency of Anticancer Drugs

inferredcites →https://doi.org/10.3390/nano9040542openalex-snapshot

Contrast Agents Delivery: An Up-to-Date Review of Nanodiagnostics in Neuroimaging

inferredcites →https://doi.org/10.3390/pharmaceutics12010020openalex-snapshot

ABC Transporters at the Blood–Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas

inferredcites →https://doi.org/10.3390/pharmaceutics13010122openalex-snapshot

Unlocking the Power of Exosomes for Crossing Biological Barriers in Drug Delivery

inferredcites →https://doi.org/10.3390/pharmaceutics13081245openalex-snapshot

Ultrasound-Mediated Blood-Brain Barrier Opening Improves Whole Brain Gene Delivery in Mice

inferredcites →https://doi.org/10.3390/pharmaceutics13111779openalex-snapshot

Blood-Brain Barrier Dysfunction in CNS Disorders and Putative Therapeutic Targets: An Overview

inferredcites →https://doi.org/10.3390/pharmaceutics9020012openalex-snapshot

Liposomal Formulations in Clinical Use: An Updated Review

inferredcites →https://doi.org/10.3390/scipharm87010006openalex-snapshot

Overcoming the Blood–Brain Barrier. Challenges and Tricks for CNS Drug Delivery

inferredcites →https://doi.org/10.3402/jev.v4.26316openalex-snapshot

Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting

inferredcites →https://doi.org/10.37483/jcp.2015.2404openalex-snapshot

SOLID LIPID NANO PARTICLES - A REVIEW

inferredcites →https://doi.org/10.4049/jimmunol.1700904openalex-snapshot

Rab27-Dependent Exosome Production Inhibits Chronic Inflammation and Enables Acute Responses to Inflammatory Stimuli

inferredcites →https://doi.org/10.4103/aian.aian_241_17openalex-snapshot

Levodopa: History and therapeutic applications

inferredcites →https://doi.org/10.7150/thno.21254openalex-snapshot

Current Strategies for Brain Drug Delivery

inferredcites →https://doi.org/10.7150/thno.40908openalex-snapshot

Investigating the effects of dexamethasone on blood-brain barrier permeability and inflammatory response following focused ultrasound and microbubble exposure

inferredcites →https://doi.org/10.7150/thno.42167openalex-snapshot

Current understanding of the role of Adipose-derived Extracellular Vesicles in Metabolic Homeostasis and Diseases: Communication from the distance between cells/tissues

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4661733openalex-extracted

Taking Advantages of Blood–Brain Barrier to Optimize Delivery of Drugs in Central Neurological Conditions

inferred← citeshttps://doi.org/10.1002/adhm.202302902openalex-snapshot

Insights into Targeted and Stimulus‐Responsive Nanocarriers for Brain Cancer Treatment

inferred← citeshttps://doi.org/10.1002/adhm.202503407openalex-snapshot

Therapeutic Materials for Ferroptosis Inhibition: from Design to Applications

inferred← citeshttps://doi.org/10.1002/adsr.202300199openalex-snapshot

Effects of Ultrasound for Bio‐Applications

inferred← citeshttps://doi.org/10.1002/adtp.202500576openalex-snapshot

Zinc‐Based Nanocomposites for Alzheimer's Therapy: Restoring Metal Homeostasis and Inhibiting Neurotoxic Protein Aggregation

inferred← citeshttps://doi.org/10.1002/adtp.70162openalex-snapshot

Molecular Docking‐Guided Engineering of TPGS/Tween 80 Mixed Micelles for the Intranasal Delivery of Paliperidone Palmitate

inferred← citeshttps://doi.org/10.1002/advs.202517004openalex-snapshot

Crossing the Blood–Brain Barrier with Molecularly Imprinted Polymeric Nanocarriers: An Emerging Frontier in Brain Disease Therapy

inferred← citeshttps://doi.org/10.1002/ange.202500247openalex-snapshot

New Transferrin Receptor‐Targeting Conjugate Effectively Delivers DNA to Mouse Brain

inferred← citeshttps://doi.org/10.1002/anie.202500247openalex-snapshot

New Transferrin Receptor‐Targeting Conjugate Effectively Delivers DNA to Mouse Brain

inferred← citeshttps://doi.org/10.1002/biot.70126openalex-snapshot

Development of Microvascular Network in Microfluidic Brain‐on‐a‐Chip Models In Vitro: A Multidisciplinary Review

inferred← citeshttps://doi.org/10.1002/cam4.70069openalex-snapshot

CNN ‐based deep learning approach for classification of invasive ductal and metastasis types of breast carcinoma

inferred← citeshttps://doi.org/10.1002/cbic.202500104openalex-snapshot

Galactose‐Functionalized Gold Nanoparticles Targeting Membrane Transporters for the Glutathione Delivery to Brain Cancer Cells

inferred← citeshttps://doi.org/10.1002/mco2.70618openalex-snapshot

Oligodendrocyte: Development, Plasticity, Biological Functions, Diseases, and Therapeutic Targets

inferred← citeshttps://doi.org/10.1002/smll.202405511openalex-snapshot

Recent Developments in Glioblastoma‐On‐A‐Chip for Advanced Drug Screening Applications

inferred← citeshttps://doi.org/10.1002/smll.202410031openalex-snapshot

ROS Regulation in CNS Disorder Therapy: Unveiling the Dual Roles of Nanomedicine

inferred← citeshttps://doi.org/10.1002/smll.202510642openalex-snapshot

Bacterial Membrane Vesicles: Next‐Generation Nanoscale Antibacterial Biomaterials

inferred← citeshttps://doi.org/10.1002/wnan.1927openalex-snapshot

Current landscape of treating different cancers using nanomedicines: Trends and perspectives

inferred← citeshttps://doi.org/10.1007/16833_2024_400openalex-snapshot

Crossing the Blood-Brain Barrier: Advancing Immunotherapy for Pediatric Brain Tumors

inferred← citeshttps://doi.org/10.1007/978-3-031-61992-2_5openalex-snapshot

The Guardian of the Brain: Understanding the Blood–Brain Barrier and its Role in CNS Drug Discovery

inferred← citeshttps://doi.org/10.1007/978-981-95-1888-3_9openalex-snapshot

Lipid-Based Micro/Nanovesicles as a Potential Strategy for Drug Delivery in Breast Cancer Treatment

inferred← citeshttps://doi.org/10.1007/978-981-96-2112-5_16openalex-snapshot

A Novel Drug Delivery System Utilizing Nanoparticles to Treat Neurological Disorders

inferred← citeshttps://doi.org/10.1007/978-981-97-4970-6_13openalex-snapshot

Targeted Brain Delivery of Therapeutics

inferred← citeshttps://doi.org/10.1007/978-981-99-3848-3_11openalex-snapshot

Stem Cells, Derived Exosomes, and Associated Signaling Molecules in Neuroprotection

inferred← citeshttps://doi.org/10.1007/978-981-99-8373-5_13openalex-snapshot

Advancement of Radiolabeled Exosomes in Brain Disorders

inferred← citeshttps://doi.org/10.1007/978-981-99-9510-3_7openalex-snapshot

Drug Delivery for Neurological Disorders Using Nanotechnology

inferred← citeshttps://doi.org/10.1007/s10118-026-3660-3openalex-snapshot

Boosting Blood-Brain Barrier Crossing with a Mannosylated Nanocarrier

inferred← citeshttps://doi.org/10.1007/s10404-024-02741-zopenalex-snapshot

Advances in modeling permeability and selectivity of the blood-brain barrier using microfluidics

inferred← citeshttps://doi.org/10.1007/s10853-024-09595-4openalex-snapshot

Application and progress of inorganic composites in haemostasis: a review

inferred← citeshttps://doi.org/10.1007/s11033-023-08625-9openalex-snapshot

Upregulation of girdin delays endothelial cell apoptosis via promoting engulfment of platelets

inferred← citeshttps://doi.org/10.1007/s11033-023-08968-3openalex-snapshot

Current non-invasive strategies for brain drug delivery: overcoming blood–brain barrier transport

inferred← citeshttps://doi.org/10.1007/s11051-024-05983-8openalex-snapshot

Advancements in neurotherapeutics: nanoparticles overcoming the blood–brain barrier for precise CNS targeting

inferred← citeshttps://doi.org/10.1007/s12015-024-10791-7openalex-snapshot

Global Trends of Exosomes Application in Clinical Trials: A Scoping Review

inferred← citeshttps://doi.org/10.1007/s12032-025-02944-6openalex-snapshot

Advanced nanotheranostic approaches for targeted glioblastoma treatment: a synergistic fusion of CRISPR-Cas gene editing, AI-driven tumor profiling, and BBB-modulation

inferred← citeshttps://doi.org/10.1007/s12035-023-03862-2openalex-snapshot

Exosome Content–Mediated Signaling Pathways in Multiple Sclerosis

inferred← citeshttps://doi.org/10.1007/s12035-025-04874-wopenalex-snapshot

Potential Roles of Natural Antioxidants in Modulating Neurodegenerative Disease Pathways

inferred← citeshttps://doi.org/10.1007/s12035-025-05003-3openalex-snapshot

Advancements in Stem Cell Research for Effective Therapies Against Alzheimer’s Disease: Current Investigation and Future Insight

inferred← citeshttps://doi.org/10.1007/s12035-025-05448-6openalex-snapshot

Antimicrobial Resistance and the Blood–Brain Barrier: Complex Interactions and Implications for Neurological Health

inferred← citeshttps://doi.org/10.1007/s12668-026-02777-1openalex-snapshot

Intranasal Delivery of Berberine via QbD-Engineered Chitosan Coated Liposomes: Formulation Fabrication and Cellular Efficacy for Alzheimer’s Intervention

inferred← citeshttps://doi.org/10.1007/s13205-023-03553-8openalex-snapshot

An update on pathogenesis and clinical scenario for Parkinson’s disease: diagnosis and treatment

inferred← citeshttps://doi.org/10.1007/s13346-024-01770-zopenalex-snapshot

Revolutionizing Parkinson’s treatment: Harnessing the potential of intranasal nanoemulsions for targeted therapy

inferred← citeshttps://doi.org/10.1007/s13346-025-01887-9openalex-snapshot

Crossing the blood–brain barrier: nanoparticle-based strategies for neurodegenerative disease therapy

inferred← citeshttps://doi.org/10.1007/s40268-026-00538-9openalex-snapshot

Advanced Drug Delivery Strategies for Overcoming Biological Barriers: Tumor Microenvironment and Blood–Brain Barrier

inferred← citeshttps://doi.org/10.1016/b978-0-443-23841-3.00005-4openalex-snapshot

ApoE potential in CNS drugs targeting and as CNS therapeutic

inferred← citeshttps://doi.org/10.1016/b978-0-443-26657-7.00008-8openalex-snapshot

Cationic nanoparticles for drug delivery targeting the brain

inferred← citeshttps://doi.org/10.1016/b978-0-443-29932-2.00014-1openalex-snapshot

Futuristic therapeutics in pipeline for the betterment of neurodegenerative disorders

inferred← citeshttps://doi.org/10.1016/b978-0-443-33382-8.00010-8openalex-snapshot

Nano lipid-drug conjugates for the treatment of Alzheimer’s disease

inferred← citeshttps://doi.org/10.1016/b978-0-443-33641-6.00005-1openalex-snapshot

Nonmetallic stimuli-responsive nanocarriers in the treatment of noncancerous disease

inferred← citeshttps://doi.org/10.1016/b978-0-443-33641-6.00021-xopenalex-snapshot

Nonmetallic nanoparticles: A therapeutic platform for nonmalignant disorders

inferred← citeshttps://doi.org/10.1016/b978-0-443-45844-6.00017-2openalex-snapshot

Challenges in recent Alzheimer's disease therapeutic approaches

inferred← citeshttps://doi.org/10.1016/j.addr.2024.115346openalex-snapshot

Exploring the potential of cell-derived vesicles for transient delivery of gene editing payloads

inferred← citeshttps://doi.org/10.1016/j.alcohol.2024.07.007openalex-snapshot

Emerging pharmacological targets for alcohol use disorder

inferred← citeshttps://doi.org/10.1016/j.arr.2024.102414openalex-snapshot

Unraveling the complexity of human brain: Structure, function in healthy and disease states

inferred← citeshttps://doi.org/10.1016/j.arr.2026.103345openalex-snapshot

The gut microbiota and gut–brain axis in Alzheimer’s disease: From pathogenesis to treatment

inferred← citeshttps://doi.org/10.1016/j.bbrc.2024.150467openalex-snapshot

Guluronic acid disaccharide inhibits reactive oxygen species production and amyloid-β oligomer formation

inferred← citeshttps://doi.org/10.1016/j.bbrc.2025.152843openalex-snapshot

Perfluorocarbon nanotechnologies for blood-brain barrier modulation: Enhancing drug delivery and neuroprotection

inferred← citeshttps://doi.org/10.1016/j.bcp.2025.116789openalex-snapshot

Nanoengineered immune check point inhibitors delivery for targeted brain cancer treatment: Current status and future perspectives

inferred← citeshttps://doi.org/10.1016/j.bioadv.2025.214474openalex-snapshot

Advanced intranasal peptide delivery systems for improved management of Alzheimer's disease

inferred← citeshttps://doi.org/10.1016/j.bios.2023.115100openalex-snapshot

Biosensor integrated brain-on-a-chip platforms: Progress and prospects in clinical translation

inferred← citeshttps://doi.org/10.1016/j.carbpol.2025.123581openalex-snapshot

Chitosan nanovectors for siRNA delivery: New horizons for nonviral gene therapy

inferred← citeshttps://doi.org/10.1016/j.cej.2025.169535openalex-snapshot

Bacterial infection hypothesis-based therapies for Alzheimer's disease

inferred← citeshttps://doi.org/10.1016/j.drudis.2023.103735openalex-snapshot

Recent advances towards overcoming the blood–brain barrier

inferred← citeshttps://doi.org/10.1016/j.dscb.2025.100284openalex-snapshot

Neuroprotective effects of natural products against doxorubicin-induced chemobrain: a narrative review of preclinical animal studies

inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e29480openalex-snapshot

Optimal timing for drug delivery into the hippocampus by focused ultrasound: A comparison of hydrophilic and lipophilic compounds

inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e29858openalex-snapshot

Immunogenic cell death mediated TLR3/4-activated MSCs in U87 GBM cell line

inferred← citeshttps://doi.org/10.1016/j.ibneur.2025.02.002openalex-snapshot

Advancing Alzheimer's Therapy: Computational strategies and treatment innovations

inferred← citeshttps://doi.org/10.1016/j.ica.2024.122285openalex-snapshot

New anticancer Pt and Pd complexes with binicotinic acid and oxalate derivatives as ligands: Synthesis, cytotoxicity, binding mode on DNA and HSA and molecular docking

inferred← citeshttps://doi.org/10.1016/j.ijft.2024.100948openalex-snapshot

Using molecular dynamics simulation to examine the evolution of blood barrier structure in the presence of different electric fields

inferred← citeshttps://doi.org/10.1016/j.ijpharm.2023.122614openalex-snapshot

Strategic nanocarriers to control neurodegenerative disorders: Concept, challenges, and future perspective

inferred← citeshttps://doi.org/10.1016/j.jconrel.2024.04.006openalex-snapshot

A blood–brain barrier- and blood–brain tumor barrier-penetrating siRNA delivery system targeting gliomas for brain tumor immunotherapy

inferred← citeshttps://doi.org/10.1016/j.jconrel.2024.06.056openalex-snapshot

Minimally invasive nasal infusion (MINI) approach for CNS delivery of protein therapeutics: A case study with ovalbumin

inferred← citeshttps://doi.org/10.1016/j.jconrel.2025.114426openalex-snapshot

Clinical translation of nanomedicines for brain diseases: Current challenges and future directions

inferred← citeshttps://doi.org/10.1016/j.jddst.2022.104074openalex-snapshot

Update on Therapeutic potential of emerging nanoformulations of phytocompounds in Alzheimer's and Parkinson's disease

inferred← citeshttps://doi.org/10.1016/j.jddst.2024.105885openalex-snapshot

Intranasal delivery of chitosan-based nanoparticles as an innovative way for management of neurodegenerative disorders: A comprehensive review of advanced strategies for CNS targeting

inferred← citeshttps://doi.org/10.1016/j.jddst.2024.106322openalex-snapshot

Nanotechnology in glioblastoma therapy: Advances in drug delivery systems and diagnostic approaches

inferred← citeshttps://doi.org/10.1016/j.jddst.2024.106398openalex-snapshot

Deciphering convection enhanced delivery: A paradigm shift for circumventing glioblastoma multiforme

inferred← citeshttps://doi.org/10.1016/j.jddst.2026.108479openalex-snapshot

Exosomes as an emerging biological nanoplatform in the management of Alzheimer's disease: Breakthroughs and bottlenecks

inferred← citeshttps://doi.org/10.1016/j.jddst.2026.108806openalex-snapshot

Emerging nano-drug delivery strategies for management of neuropsychiatric disorders

inferred← citeshttps://doi.org/10.1016/j.jnrt.2024.100111openalex-snapshot

Liposome-based loading enhances the distribution of nicotinamide riboside chloride into the brain and its neuroprotective effects in cerebral ischemic mice

inferred← citeshttps://doi.org/10.1016/j.jpha.2026.101643openalex-snapshot

Nanotechnology-enabled strategies to overcome the blood–brain barrier for glioma treatment

inferred← citeshttps://doi.org/10.1016/j.lfs.2024.123155openalex-snapshot

Surface engineered nano architectonics: An evolving paradigm for tackling Alzheimer's disease

inferred← citeshttps://doi.org/10.1016/j.molliq.2023.122749openalex-snapshot

Riluzole-loaded lipid nanoparticles for brain delivery: Preparation, optimization and characterization

inferred← citeshttps://doi.org/10.1016/j.mtchem.2025.103314openalex-snapshot

MOF and COF-based drug delivery system for Parkinson's disease: Mechanism, future and development of artificial intelligence

inferred← citeshttps://doi.org/10.1016/j.mvr.2023.104621openalex-snapshot

Blood-brain barrier permeability in the ischemic stroke: An update

inferred← citeshttps://doi.org/10.1016/j.neuroscience.2025.06.037openalex-snapshot

Role of Blood-Brain barrier in bacterial translocation

inferred← citeshttps://doi.org/10.1016/j.omtn.2024.102131openalex-snapshot

Anti-miRNA103/107 encapsulated in transferrin-conjugated lipid nanoparticles crosses blood-brain barrier and reduces brain ischemic damage

inferred← citeshttps://doi.org/10.1016/j.peptides.2024.171298openalex-snapshot

The role of CART peptide in learning and memory: A potential therapeutic target in memory-related disorders

inferred← citeshttps://doi.org/10.1016/j.smaim.2022.11.001openalex-snapshot

Advances in mRNA nanomedicines for malignant brain tumor therapy

inferred← citeshttps://doi.org/10.1016/j.tice.2026.103524openalex-snapshot

Blood-brain barrier modulation for targeted central nervous system drug delivery in neurodegenerative and demyelinating disorders

inferred← citeshttps://doi.org/10.1021/acs.jcim.5c02552openalex-snapshot

Rapid Parallel Virtual Screening Aids the Discovery of Novel P-Glycoprotein Inhibitors

inferred← citeshttps://doi.org/10.1021/acs.molpharmaceut.5c00297openalex-snapshot

Challenges and Opportunities for Incorporating Physiological Information into Pharmacokinetic Models of Intranasal Drug Delivery to the Brain: A Review of the Current Status and Future Trajectories

inferred← citeshttps://doi.org/10.1021/acsbiomaterials.5c00218openalex-snapshot

Empowering Healthcare with Phage Display Technology

inferred← citeshttps://doi.org/10.1021/acschemneuro.3c00743openalex-snapshot

Patient-Derived Blood-Brain Barrier Model for Screening Copper Bis(thiosemicarbazone) Complexes as Potential Therapeutics in Alzheimer’s Disease

inferred← citeshttps://doi.org/10.1021/acschemneuro.5c00484openalex-snapshot

Antibody Therapies for Alzheimer’s Disease: A New Strategy for Targeted Therapy and Blood–Brain Barrier Delivery

inferred← citeshttps://doi.org/10.1021/acschemneuro.6c00245openalex-snapshot

Biomaterials and Nanoparticle-Based Therapeutics in Neurodegenerative Diseases: Bridging the Gap Between Innovation and Translation

inferred← citeshttps://doi.org/10.1021/acsomega.4c08669openalex-snapshot

Global Advancements in Bioactive Material Manufacturing for Drug Delivery: A Comprehensive Study

inferred← citeshttps://doi.org/10.1021/acsomega.5c00405openalex-snapshot

Penetration of the Blood–Brain Barrier and Liver for Repairing Motor Disorders in a Rat Model of Parkinson’s Disease Using a Nanocopolymer

inferred← citeshttps://doi.org/10.1021/acssensors.5c01862openalex-snapshot

Light-Assisted Activation Probes for Time-Controllable Monitoring of O 2 •– in Cerebral Ischemia-Reperfusion Injury

inferred← citeshttps://doi.org/10.1038/s41417-025-00906-8openalex-snapshot

Lactate-coated polyurea-siRNA dendriplex: a gene therapy-directed and metabolism-based strategy to impair glioblastoma (GBM)

inferred← citeshttps://doi.org/10.1038/s41598-025-02412-1openalex-snapshot

Aducanumab delivery via focused ultrasound-induced transient blood–brain barrier opening in vivo

inferred← citeshttps://doi.org/10.1038/s41598-025-03962-0openalex-snapshot

Anti-amyloidogenic properties of 5‑caffeoylquinic acid-capped selenium nanoparticles

inferred← citeshttps://doi.org/10.1039/d3bm01055dopenalex-snapshot

Exosomes encapsulated in hydrogels for effective central nervous system drug delivery

inferred← citeshttps://doi.org/10.1039/d4bm01503gopenalex-snapshot

Diagnostics of brain tumor in the early stage: current status and future perspectives

inferred← citeshttps://doi.org/10.1039/d4ra08128eopenalex-snapshot

Nanoscale drug formulations for the treatment of Alzheimer's disease progression

inferred← citeshttps://doi.org/10.1039/d5bm00066aopenalex-snapshot

Mechanistic insights into a thermoresponsive in situ nanoemulgel of azilsartan medoxomil for intranasal delivery: a promising nanotherapeutic approach to target dementia

inferred← citeshttps://doi.org/10.1039/d5ob01119aopenalex-snapshot

A high lipid-soluble probe for ONOO − recognition in the endoplasmic reticulum and imaging of cerebral ischemia-reperfusion injury

inferred← citeshttps://doi.org/10.1055/a-2795-3386openalex-snapshot

Design, Optimization, and in vitro Characterization of Riluzole-Loaded Polymeric Micelles for Enhanced Delivery in Amyotrophic Lateral Sclerosis

inferred← citeshttps://doi.org/10.1080/02652048.2024.2404414openalex-snapshot

A comprehensive review on lipid-based nanoparticles via nose to brain targeting as a novel approach

inferred← citeshttps://doi.org/10.1080/14728222.2023.2206561openalex-snapshot

Focusing on oligomeric tau as a therapeutic target in Alzheimer’s disease and other tauopathies

inferred← citeshttps://doi.org/10.1080/14728222.2026.2671696openalex-snapshot

Identifying targets at the blood-brain barrier for treating vascular cognitive impairment and dementia

inferred← citeshttps://doi.org/10.1080/15685551.2025.2464132openalex-snapshot

A comprehensive insight of innovations and recent advancements in nanocarriers for nose-to-brain drug targeting

inferred← citeshttps://doi.org/10.1080/17425247.2024.2369765openalex-snapshot

Brain delivery enabled by transient blood–brain barrier disruption induced by regadenoson: a PET imaging study

inferred← citeshttps://doi.org/10.1080/17435889.2024.2435242openalex-snapshot

The therapeutic potential of immunomodulatory nucleic acid nanoparticles in the treatment of CNS infections

inferred← citeshttps://doi.org/10.1080/17590914.2025.2495632openalex-snapshot

P-glycoprotein and Alzheimer’s Disease: Threats and Opportunities

inferred← citeshttps://doi.org/10.1080/21655979.2024.2401269openalex-snapshot

Engineering with Biomedical Sciences Changing the Horizon of Healthcare-A Review

inferred← citeshttps://doi.org/10.1080/21688370.2025.2607157openalex-snapshot

Potential of exosomes for targeted therapy in neuroinfectious disease management: crossing the blood–brain barrier

inferred← citeshttps://doi.org/10.1111/ejn.70142openalex-snapshot

Nano‐Chaperones: Bridging Therapeutics for Amyloid Aggregation in Alzheimer's Disease and Type‐2 Diabetes Mellitus

inferred← citeshttps://doi.org/10.1124/jpet.123.001689openalex-snapshot

Metallic Nanocarriers for Therapeutic Peptides: Emerging Solutions Addressing the Delivery Challenges in Brain Ailments

inferred← citeshttps://doi.org/10.11648/j.ajbio.20231102.12openalex-snapshot

Computational Exploration of Vitis vinifera-Derived Molecules as SARS-CoV-2 Main Protease Inhibitors: A Quantum Chemical and Molecular Modeling Approach

inferred← citeshttps://doi.org/10.1177/25424823251343789openalex-snapshot

Efficacy and safety of focused ultrasound-mediated blood-brain barrier opening in Alzheimer's disease: A systematic review and meta-analysis

inferred← citeshttps://doi.org/10.1186/s12302-026-01369-wopenalex-snapshot

Nanoparticles-induced brain injury: prevalence, mechanisms, and implications

inferred← citeshttps://doi.org/10.1186/s12967-023-04192-6openalex-snapshot

Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer’s disease patients

inferred← citeshttps://doi.org/10.1186/s12967-026-08052-xopenalex-snapshot

Mesenchymal stem cells and secretome as modulators of neuroinflammation in neurological disorders

inferred← citeshttps://doi.org/10.1186/s13064-026-00298-xopenalex-snapshot

Ligand directed nanocarriers enable brain selective neuroprotection through optimized blood brain barrier transport and translational design

inferred← citeshttps://doi.org/10.1186/s13064-026-00316-yopenalex-snapshot

Engineering chitosan functionalized extracellular vesicles for targeted brain gene delivery and neurotherapeutics

inferred← citeshttps://doi.org/10.1186/s40001-024-01915-3openalex-snapshot

Alzheimer’s disease and drug delivery across the blood–brain barrier: approaches and challenges

inferred← citeshttps://doi.org/10.1208/s12249-024-02946-zopenalex-snapshot

Non-Invasive Techniques of Nose to Brain Delivery Using Nanoparticulate Carriers: Hopes and Hurdles

inferred← citeshttps://doi.org/10.1208/s12249-026-03398-3openalex-snapshot

Effective Brain Targeting Using the Self-Emulsifying Drug Delivery Systems

inferred← citeshttps://doi.org/10.12677/acm.2024.1472143openalex-snapshot

Research Progress on the Correlation between MECT and VEGF Expression in Patients with Depression

inferred← citeshttps://doi.org/10.12923/cipms-2025-0002openalex-snapshot

Solid lipid nanoparticle a complete tool for brain targeted drug delivery

inferred← citeshttps://doi.org/10.13040/ijpsr.0975-8232.14(1).80-89openalex-snapshot

inferred← citeshttps://doi.org/10.13040/ijpsr.0975-8232.15(7).2222-29openalex-snapshot

inferred← citeshttps://doi.org/10.1371/journal.pone.0340202openalex-snapshot

Conjugation of a Cryptococcus neoformans-derived metalloprotease to antifungal-loaded PLGA nanoparticles treats neural cryptococcosis in an in vitro model

inferred← citeshttps://doi.org/10.1515/nipt-2026-0010openalex-snapshot

Emerging drug delivery system to the brain: using extracellular vesicles and liposomes hybrid platform

inferred← citeshttps://doi.org/10.1515/tnsci-2022-0258openalex-snapshot

Nanotechnology-based drug delivery for the treatment of CNS disorders

inferred← citeshttps://doi.org/10.17816/phf120109openalex-snapshot

Molecular mechanisms of transport of substances across the blood-brain barrie as targets for pharmacological action. Part 2. Modern methods of delivery of pharmacological agents to the central nervous system

inferred← citeshttps://doi.org/10.2147/ijn.s442520openalex-snapshot

How Precise are Nanomedicines in Overcoming the Blood–Brain Barrier? A Comprehensive Review of the Literature

inferred← citeshttps://doi.org/10.2147/ijn.s443498openalex-snapshot

A Pralidoxime Nanocomplex Formulation Targeting Transferrin Receptors for Reactivation of Brain Acetylcholinesterase After Exposure of Mice to an Anticholinesterase Organophosphate

inferred← citeshttps://doi.org/10.2147/ijn.s457393openalex-snapshot

Advancing CNS Therapeutics: Enhancing Neurological Disorders with Nanoparticle-Based Gene and Enzyme Replacement Therapies

inferred← citeshttps://doi.org/10.2174/0113816128348877241202053633openalex-snapshot

Prospective Utilization of Nanocarriers Loaded with Drug Combination for Treating Alzheimer's Disease

inferred← citeshttps://doi.org/10.2174/0115672050386924250930184405openalex-snapshot

Innovative Approaches in Molecular Docking for the Discovery of Novel Inhibitors Against Alzheimer's Disease

inferred← citeshttps://doi.org/10.2174/0115680096355101250120114819openalex-snapshot

Advanced Engineered Nanoplatforms to Overcome Biological Barriers for Targeting Brain Tumors

inferred← citeshttps://doi.org/10.2174/0115680266347890250409153450openalex-snapshot

Alzheimer's Disease and Polymeric Nanocarriers: Synergistic Advances in Targeted Drug Delivery

inferred← citeshttps://doi.org/10.2174/0118753183367402241216115139openalex-snapshot

Lipoprotein Lipase and Neurological Health: Investigating its Impact on Brain Function and Alzheimer's Disease

inferred← citeshttps://doi.org/10.2174/0122103031375761250801075431openalex-snapshot

Redefining Neuropsychiatric Disorder Treatment: Innovations in Drug Design and Targeted Therapy

inferred← citeshttps://doi.org/10.2174/1381612829666230803114513openalex-snapshot

In-situ Gels for Brain Delivery: Breaching the Barriers

inferred← citeshttps://doi.org/10.2174/1389200223666220817115003openalex-snapshot

Dysfunction of ABC Transporters at the Surface of BBB: Potential Implications in Intractable Epilepsy and Applications of Nanotechnology Enabled Drug Delivery

inferred← citeshttps://doi.org/10.2174/1566523222666221004100858openalex-snapshot

Current Landscape and Emerging Opportunities of Gene Therapy with Non-viral Episomal Vectors

inferred← citeshttps://doi.org/10.2174/9789815324846125010005openalex-snapshot

Nano carriers Containing Bioactive Compounds for Targeting Neurodegenerative Disorders

inferred← citeshttps://doi.org/10.22159/ijap.2025v17i2.52932openalex-snapshot

MOLECULAR DOCKING AND PHARMACOKINETIC EVALUATION OF NANOHERBAL SENDUDUK BULU (MICONIA CRENATA (VAHL.) MICHELANG.) COMPOUNDS AS AKT1 INHIBITORS

inferred← citeshttps://doi.org/10.3233/jad-230603openalex-snapshot

Immunotherapy in Alzheimer’s Disease: Current Status and Future Directions

inferred← citeshttps://doi.org/10.3389/fcell.2025.1674333openalex-snapshot

Skeleton keys and Trojan horses: a review of therapeutic delivery to the brain

inferred← citeshttps://doi.org/10.3389/fmed.2025.1522223openalex-snapshot

Targeted drug delivery in neurodegenerative diseases: the role of nanotechnology

inferred← citeshttps://doi.org/10.3389/fnagi.2024.1329357openalex-snapshot

Emerging role of mesenchymal stem cells-derived extracellular vesicles in vascular dementia

inferred← citeshttps://doi.org/10.3389/fneur.2023.1324216openalex-snapshot

Navigating the brain: the role of exosomal shuttles in precision therapeutics

inferred← citeshttps://doi.org/10.3389/fonc.2026.1717432openalex-snapshot

Brain metastases from non-small cell lung cancer: molecular subtypes and emerging CNS-directed precision therapies

inferred← citeshttps://doi.org/10.3390/biom14091104openalex-snapshot

New BDNF and NT-3 Cyclic Mimetics Concur with Copper to Activate Trophic Signaling Pathways as Potential Molecular Entities to Protect Old Brains from Neurodegeneration

inferred← citeshttps://doi.org/10.3390/biom16010027openalex-snapshot

From Mechanism to Medicine: Peptide-Based Approaches for Cancer Diagnosis and Therapy

inferred← citeshttps://doi.org/10.3390/biomedicines13102476openalex-snapshot

Synthesis, Characterization, and Anti-Glioblastoma Activity of Andrographolide–Iron Oxide Nanoparticles (AG-IONPs)

inferred← citeshttps://doi.org/10.3390/cells12010192openalex-snapshot

Morphological and Functional Effects of Ultrasound on Blood–Brain Barrier Transitory Opening: An In Vitro Study on Rat Brain Endothelial Cells

inferred← citeshttps://doi.org/10.3390/ijms232213954openalex-snapshot

Alzheimer’s Disease: Treatment Strategies and Their Limitations

inferred← citeshttps://doi.org/10.3390/ijms24119218openalex-snapshot

Screening of the Anti-Neurodegenerative Activity of Caffeic Acid after Introduction into Inorganic Metal Delivery Systems to Increase Its Solubility as the Result of a Mechanosynthetic Approach

inferred← citeshttps://doi.org/10.3390/ijms241411780openalex-snapshot

Exploring the Potential of Aptamers in Targeting Neuroinflammation and Neurodegenerative Disorders: Opportunities and Challenges

inferred← citeshttps://doi.org/10.3390/ijms251910632openalex-snapshot

Intrathecal Immunoselective Nanopheresis for Alzheimer’s Disease: What and How? Why and When?

inferred← citeshttps://doi.org/10.3390/ijms252111494openalex-snapshot

Combining Phototherapy and Gold-Based Nanomaterials: A Breakthrough in Basal Cell Carcinoma Treatment

inferred← citeshttps://doi.org/10.3390/ijms252211888openalex-snapshot

Structure–Tissue Exposure/Selectivity Relationship (STR) on Carbamates of Cannabidiol

inferred← citeshttps://doi.org/10.3390/ijms26125843openalex-snapshot

Brain Endothelial Cells in Blood–Brain Barrier Regulation and Neurological Therapy

inferred← citeshttps://doi.org/10.3390/ijms26199478openalex-snapshot

Microfluidic-Based Technologies for Crossing the Blood–Brain Barrier Against Alzheimer’s Disease: Novel Strategies and Challenges

inferred← citeshttps://doi.org/10.3390/ijms262311541openalex-snapshot

Modulating Cerebrospinal Fluid Composition in Neurodegenerative Processes: Modern Drug Delivery and Clearance Strategies

inferred← citeshttps://doi.org/10.3390/ijms27052370openalex-snapshot

From Polyphenols to Prodrugs: Bridging the Blood–Brain Barrier with Nanomedicine and Neurotherapeutics

inferred← citeshttps://doi.org/10.3390/jcm11195846openalex-snapshot

Nanoporous Membranes for the Filtration of Proteins from Biological Fluids: Biocompatibility Tests on Cell Cultures and Suggested Applications for the Treatment of Alzheimer’s Disease

inferred← citeshttps://doi.org/10.3390/molecules30071555openalex-snapshot

Inhibitory Potential of the Drimane Sesquiterpenoids Isotadeonal and Polygodial in the NF-kB Pathway

inferred← citeshttps://doi.org/10.3390/ph17030366openalex-snapshot

Niosomal Bupropion: Exploring Therapeutic Frontiers through Behavioral Profiling

inferred← citeshttps://doi.org/10.3390/ph18050751openalex-snapshot

Near-Infrared Photoimmunotherapy in Brain Tumors—An Unexplored Frontier

inferred← citeshttps://doi.org/10.3390/ph18060871openalex-snapshot

Thermosensitive Mucoadhesive Intranasal In Situ Gel of Risperidone for Nose-to-Brain Targeting: Physiochemical and Pharmacokinetics Study

inferred← citeshttps://doi.org/10.3390/pharmaceutics14081737openalex-snapshot

New Strategies for Stroke Therapy: Nanoencapsulated Neuroglobin

inferred← citeshttps://doi.org/10.3390/pharmaceutics14081748openalex-snapshot

An Updated Overview of Cyclodextrin-Based Drug Delivery Systems for Cancer Therapy

inferred← citeshttps://doi.org/10.3390/pharmaceutics14091950openalex-snapshot

Oxime Therapy for Brain AChE Reactivation and Neuroprotection after Organophosphate Poisoning

inferred← citeshttps://doi.org/10.3390/pharmaceutics14112370openalex-snapshot

Membrane Vesicles Derived from Gut Microbiota and Probiotics: Cutting-Edge Therapeutic Approaches for Multidrug-Resistant Superbugs Linked to Neurological Anomalies

inferred← citeshttps://doi.org/10.3390/pharmaceutics17010128openalex-snapshot

Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy

inferred← citeshttps://doi.org/10.3390/pharmaceutics17030280openalex-snapshot

Trojan Horse Delivery Strategies of Natural Medicine Monomers: Challenges and Limitations in Improving Brain Targeting

inferred← citeshttps://doi.org/10.3390/pharmaceutics17050661openalex-snapshot

Advancing Brain Targeting: Cost-Effective Surface-Modified Nanoparticles for Faster Market Entry

inferred← citeshttps://doi.org/10.3390/polym15193969openalex-snapshot

Recent Advancements and Strategies for Overcoming the Blood–Brain Barrier Using Albumin-Based Drug Delivery Systems to Treat Brain Cancer, with a Focus on Glioblastoma

inferred← citeshttps://doi.org/10.3390/toxins15080506openalex-snapshot

Of Seven New K+ Channel Inhibitor Peptides of Centruroides bonito, α-KTx 2.24 Has a Picomolar Affinity for Kv1.2

inferred← citeshttps://doi.org/10.34172/apb.025.44026openalex-snapshot

Monoclonal antibody-anchored quantum dots-based delivery strategies for glioblastoma treatment: Challenges and applications

inferred← citeshttps://doi.org/10.3762/bjnano.15.113openalex-snapshot

Nanotechnological approaches for efficient N2B delivery: from small-molecule drugs to biopharmaceuticals

inferred← citeshttps://doi.org/10.4018/979-8-3373-1365-8.ch012openalex-snapshot

Nanotechnology and Secondary Metabolites

inferred← citeshttps://doi.org/10.4018/979-8-3373-1365-8.ch016openalex-snapshot

Emerging Trends in the Treatment of Neurodegenerative Diseases

inferred← citeshttps://doi.org/10.4018/979-8-3373-2695-5.ch008openalex-snapshot

Drug Repurposing and Overcoming the Blood-Brain Barrier for Glioblastoma

inferred← citeshttps://doi.org/10.4103/1673-5374.358619openalex-snapshot

Neurotrophic factor-based pharmacological approaches in neurological disorders

inferred← citeshttps://doi.org/10.4103/nrr.nrr-d-24-00539openalex-snapshot

Progress of research in the application of ultrasound technology for the treatment of Alzheimer’s disease

inferred← citeshttps://doi.org/10.54878/wys7ea23openalex-snapshot

Nanotechnology - an innovative approach to cope with the distinctive challenges linked with Autism Spectrum Disorder

inferred← citeshttps://doi.org/10.5599/admet.2043openalex-snapshot

Nanomaterials as drug delivery agents for overcoming the blood-brain barrier: A comprehensive review

inferred← citeshttps://doi.org/10.5599/admet.2988openalex-snapshot

Advancing through the blood-brain barrier: mechanisms, challenges and drug delivery strategies

inferred← citeshttps://doi.org/10.56083/rcv3n7-086openalex-snapshot

NANOTECNOLOGIA COMO FERRAMENTA FARMACOCINÉTICA PARA O TRATAMENTO DE DOENÇAS NEUROLÓGICAS

inferred← citeshttps://doi.org/10.59717/j.xinn-med.2025.100121openalex-snapshot

Non-invasive neuromodulation assisted by exogenous stimuli-responsive nanoplatforms for Alzheimer’s disease and Parkinson's disease therapy

inferred← citeshttps://doi.org/10.6084/m9.figshare.26590631openalex-snapshot

Additional file 1 of Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer’s disease patients

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.